Cerebrovascular disease (CVD) and Alzheimer's disease (AD) have more in common than
their association with ageing. They share risk factors and overlap neuropathologically. Most …

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disease with multifaceted
neuropathological disorders. AD is characterized by intracellular accumulation of …

Alzheimer's disease is a chronic and degenerative condition that had no treatment until
recently. The current therapeutic strategies reduce progression of the disease but are …

Neurological disorders represent major health concerns in terms of comorbidity and
mortality worldwide. Despite a tremendous increase in our understanding of the …

Abstract Purpose of Review To provide an overview of the association between angiotensin
II receptor blocker (ARB) use and cognitive outcomes. Recent Findings ARBs have …

Alzheimer's disease (AD) is characterized by the presence of proteinaceous brain deposits,
brain atrophy, vascular dysfunction, and chronic inflammation. Along with cerebral …

Alzheimer's disease has become a major public health issue. While extensive research has
been conducted in the last few decades, few drugs have been approved by the FDA to treat …

Neuropeptides are small proteins broadly expressed throughout the central nervous system,
which act as neurotransmitters, neuromodulators and neuroregulators. Growing evidence …

Synaptic plasticity is a cellular process involved in learning and memory whose alteration in
its two main forms (Long Term Depression (LTD) and Long Term Potentiation (LTP)), is …

Background Recent evidence suggests that the inducible kinin B 1 receptor (B 1 R)
contributes to pathogenic neuroinflammation induced by amyloid-beta (Aβ) peptide. The …